A human cell-free translation screen identifies the NT-2 mycotoxin as a ribosomal inhibitor that binds the peptidyl transferase center
Nino SchwalleriD, Dominic Andenmatten, Jonas Luginbühl, Julius RabliD, Helena BauriD, Marc ChamboniD, J.-M. VesiniD, Gerardo TurcattiiD, Evangelos D. KarousisiD
Abstract
Translation inhibitors are invaluable for probing ribosome function and therapeutic applications, but systematic discovery in human systems is limited by the lack of scalable, screening-compatible cell-free platforms. Here, we establish a robust high-throughput screening using human lysates that bypasses cellular cytotoxic effects. After screening [~]28,000 small molecules, we identified known and a novel translation inhibitor, including NT-2, a trichothecene mycotoxin produced by the pathogenic Fusarium sporotrichioides. NT-2 suppressed protein synthesis in human cells and yeast lysates, while sparing translation in bacteria and intact yeast cells. Cryo-EM at 1.76 [A] revealed NT-2 bound at the peptidyl transferase center of the human 60S ribosome, confirming NT-2 as a ribosomal inhibitor associated with ribosomes in an inactive eEF2/SERBP1-associated dormant state. Together, these results expose NT-2 as a previously unrecognized environmental inhibitor of mammalian protein synthesis and demonstrate the power of cell-free translation screening to reveal new inhibitors with unexpected ribosome fates.
02 /Specification & Classification
Click any tag to browse matching papers- Citations
- 0
- FWCI
- 0.00
- Field percentile
- top 37%
- Organism
- Assay
- Research Focus
- Approach
Reproducibility ledger
Nobody has reported trying to reproduce this paper yet. Did you replicate an experiment or run the code? Your report saves the next lab a week.
Sign in to file a reproducibility report.
Related papers
- Discovery of small-molecule inhibitors targeting the ribosomal peptidyl transferase center (PTC) of M. tuberculosis
B. Tam, D. Sherf, … B. Akabayov·bioRxiv·Aug 11, 2019
- Context-dependent translation inhibition as a novel oncology therapeutic modality
Paige D. Diamond, Paul Victor Sauer, … Anthony P. Schuller·bioRxiv·Jan 9, 2025
- Determining the off-target activity of antibiotics and novel translation initiation sites in mitochondria
James Marks, Emma Young, Markus Hafner·bioRxiv·Aug 29, 2024
- Human ribosomes interactions reveal the binding landscape of neomycin
Meng Wu, Lingfan Zhu, … Wen‐Fei Li·bioRxiv·Jul 22, 2025
- Structure and function of the bacterial protein toxin phenomycin
B. K. Hansen, C. K. Larsen, … T. B. Poulsen·bioRxiv·Nov 29, 2019
- A trans-translation inhibitor kills Mycobacterium tuberculosis by targeting ribosomal protein bL12
Akanksha Varshney, John N. Alumasa, … Kenneth C. Keiler·bioRxiv·Jun 2, 2025